Literature DB >> 21371418

Development of fluorescent substrates for microsomal epoxide hydrolase and application to inhibition studies.

Christophe Morisseau1, Maud Bernay, Aurélie Escaich, James R Sanborn, Jozsef Lango, Bruce D Hammock.   

Abstract

The microsomal epoxide hydrolase (mEH) plays a significant role in the metabolism of numerous xenobiotics. In addition, it has a potential role in sexual development and bile acid transport, and it is associated with a number of diseases such as emphysema, spontaneous abortion, eclampsia, and several forms of cancer. Toward developing chemical tools to study the biological role of mEH, we designed and synthesized a series of absorbent and fluorescent substrates. The highest activity for both rat and human mEH was obtained with the fluorescent substrate cyano(6-methoxy-naphthalen-2-yl)methyl glycidyl carbonate (11). An in vitro inhibition assay using this substrate ranked a series of known inhibitors similarly to the assay that used radioactive cis-stilbene oxide but with a greater discrimination between inhibitors. These results demonstrate that the new fluorescence-based assay is a useful tool for the discovery of structure-activity relationships among mEH inhibitors. Furthermore, this substrate could also be used for the screening chemical library with high accuracy and with a Z' value of approximately 0.7. This new assay permits a significant decrease in labor and cost and also offers the advantage of a continuous readout. However, it should not be used with crude enzyme preparations due to interfering reactions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371418      PMCID: PMC3090455          DOI: 10.1016/j.ab.2011.02.038

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  42 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies.

Authors:  Paul D Jones; Nicola M Wolf; Christophe Morisseau; Paul Whetstone; Bertold Hock; Bruce D Hammock
Journal:  Anal Biochem       Date:  2005-08-01       Impact factor: 3.365

Review 3.  DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides.

Authors:  J Szeliga; A Dipple
Journal:  Chem Res Toxicol       Date:  1998-01       Impact factor: 3.739

Review 4.  Epoxide hydrolases: biochemistry and molecular biology.

Authors:  A J Fretland; C J Omiecinski
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

5.  Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene.

Authors:  M Miyata; G Kudo; Y H Lee; T J Yang; H V Gelboin; P Fernandez-Salguero; S Kimura; F J Gonzalez
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

6.  Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis.

Authors:  Mala Pande; Christopher I Amos; Cathy Eng; Marsha L Frazier
Journal:  Mol Carcinog       Date:  2010-11       Impact factor: 4.784

7.  Inhibition of human m-epoxide hydrolase gene expression in a case of hypercholanemia.

Authors:  Qin-shi Zhu; Wenxue Xing; Bin Qian; Patricia von Dippe; Benjamin L Shneider; Victor L Fox; Daniel Levy
Journal:  Biochim Biophys Acta       Date:  2003-07-30

8.  Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk.

Authors:  Jordi To-Figueras; Manuel Gené; Jesús Gómez-Catalán; Esther Piqué; Natividad Borrego; Manuel Caballero; Francesc Cruellas; Anna Raya; Manuel Dicenta; Jacint Corbella
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

Review 9.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

10.  Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors.

Authors:  Christophe Morisseau; Oleg Merzlikin; Amy Lin; Guochun He; Wei Feng; Isela Padilla; Michael S Denison; Isaac N Pessah; Bruce D Hammock
Journal:  Environ Health Perspect       Date:  2009-07-31       Impact factor: 9.031

View more
  8 in total

1.  In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Authors:  Zhican Wang; Ying Fang; Juli Teague; Hansen Wong; Christophe Morisseau; Bruce D Hammock; Dan A Rock; Zhengping Wang
Journal:  Drug Metab Dispos       Date:  2017-04-20       Impact factor: 3.922

2.  LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide.

Authors:  Amy A Rand; Patrick O Helmer; Bora Inceoglu; Bruce D Hammock; Christophe Morisseau
Journal:  Methods Mol Biol       Date:  2018

3.  Cloning and characterization of a microsomal epoxide hydrolase from Heliothis virescens.

Authors:  Shizuo G Kamita; Kohji Yamamoto; Mary M Dadala; Khavong Pha; Christophe Morisseau; Aurélie Escaich; Bruce D Hammock
Journal:  Insect Biochem Mol Biol       Date:  2012-12-28       Impact factor: 4.714

4.  Inhibiting an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa Protects CFTR.

Authors:  Christopher D Bahl; Kelli L Hvorecny; Jennifer M Bomberger; Bruce A Stanton; Bruce D Hammock; Christophe Morisseau; Dean R Madden
Journal:  Angew Chem Int Ed Engl       Date:  2015-07-01       Impact factor: 15.336

Review 5.  Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.

Authors:  Qiang Jin; JingJing Wu; Yue Wu; Hongxin Li; Moshe Finel; Dandan Wang; Guangbo Ge
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

6.  Nanobody-based binding assay for the discovery of potent inhibitors of CFTR inhibitory factor (Cif).

Authors:  Natalia Vasylieva; Seiya Kitamura; Jiexian Dong; Bogdan Barnych; Kelli L Hvorecny; Dean R Madden; Shirley J Gee; Dennis W Wolan; Christophe Morisseau; Bruce D Hammock
Journal:  Anal Chim Acta       Date:  2019-01-09       Impact factor: 6.558

7.  Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa.

Authors:  Seiya Kitamura; Kelli L Hvorecny; Jun Niu; Bruce D Hammock; Dean R Madden; Christophe Morisseau
Journal:  J Med Chem       Date:  2016-05-04       Impact factor: 7.446

8.  Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues.

Authors:  Christophe Morisseau; Sean D Kodani; Shizuo G Kamita; Jun Yang; Kin Sing Stephen Lee; Bruce D Hammock
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.